TOT BIOPHARM International Co. Ltd. Financial Overview
TOT BIOPHARM International Co. Ltd.'s market cap is currently HK$1.50B. The company's EPS TTM is HK$0.011047306800000002; its P/E ratio is 184.76; TOT BIOPHARM International Co. Ltd. is scheduled to report earnings on August 12, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
